VLP Therapeutics

Recent Finacing

Series A I

Recent Raise

$21M

VLP Therapeutics is a biotech company developing virus‑like particle (VLP) platform vaccines, advancing R&D programs for cancer therapeutics and prophylactic vaccines against malaria, dengue, and COVID‑19 toward clinical trials.

Founded 2012

Maryland, United States

1-10

Private

vlptherapeutics.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Medical Device

Recent Investors

S

R

Financials

$37M

Total Raised

2

Funding rounds

7

Investors

Team

Upgrade to view the team

See the team members at VLP Therapeutics.